Literature DB >> 8985208

Alteration of interleukin-2 (IL-2) and soluble IL-2 receptor secretion in the sera and urine of patients with rickettsial boutonneuse fever.

S Mansueto1, F P D'Ancona, P Colletti, R Graceffa, F La Seta, V Pecoraro, G Gambino, G Grillo, G Vitale, P Richiusa, P D'Agostino, E Cillari.   

Abstract

Sera and urine samples from 115 Sicilian patients with boutonneuse fever (BF), obtained at the time of diagnosis and after clinical recovery, were analyzed for concentrations of interleukin (IL)-2 and soluble IL-2 receptor (sIL-2R). There were significantly high levels of sIL-2R in the urine and sera of patients with acute BF compared with healthy controls, and the values returned to normal following successful chemotherapy. The data indicate that the sIL-2R urine concentrations correlated directly with the sIL-2R sera levels. In contrast, in all tested sera and urine samples, IL-2 levels were normal. Furthermore, a reduction in IL-2 production by peripheral blood mononuclear cells from acute BF patients was also observed. sIL-2R represents an unspecific marker useful to monitor the evolution of BF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985208     DOI: 10.1093/infdis/175.1.142

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.

Authors:  S Mansueto; G Vitale; C Mocciaro; G Gambino; P Colletti; P Mansueto; A Spinelli; M Affronti; N Chifari; F Arcoleo; S Milano; E Cillari
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 2.  New insight into immunity and immunopathology of Rickettsial diseases.

Authors:  Pasquale Mansueto; Giustina Vitale; Antonio Cascio; Aurelio Seidita; Ilenia Pepe; Antonio Carroccio; Salvatore di Rosa; Giovam Battista Rini; Enrico Cillari; David H Walker
Journal:  Clin Dev Immunol       Date:  2011-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.